Free Trial
NASDAQ:OACC

Oaktree Acquisition Corp. III Life Sciences (OACC) Stock Price, News & Analysis

$10.24 +0.02 (+0.20%)
As of 11:49 AM Eastern

About Oaktree Acquisition Corp. III Life Sciences Stock (NASDAQ:OACC)

Key Stats

Today's Range
$10.19
$10.24
50-Day Range
N/A
52-Week Range
$9.95
$10.85
Volume
1,454 shs
Average Volume
110,639 shs
Market Capitalization
$229.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

We are a newly organized blank check company incorporated on June 28, 2024, as a Cayman Islands exempted company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. To date, our efforts have been limited to organizational activities as well as activities related to this offering. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. We have generated no operating revenues to date and we do not expect that we will generate operating revenues until we consummate our initial business combination. While we may pursue an acquisition opportunity in any business, industry, sector, or geographical location, we intend to focus on industries that complement our management team’s background, and to capitalize on the ability of our management team to identify and acquire a business, focusing on the healthcare or healthcare-related industries. In particular, we intend to target North American, British or European companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors where our management has extensive investment experience. Our executive offices are located at 333 South Grand Avenue, 28th Floor, Los Angeles, California 90071.

Remove Ads
Receive OACC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oaktree Acquisition Corp. III Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

OACC Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

OACC Stock Analysis - Frequently Asked Questions

Oaktree Acquisition Corp. III Life Sciences' stock was trading at $10.01 on January 1st, 2025. Since then, OACC stock has increased by 1.8% and is now trading at $10.19.
View the best growth stocks for 2025 here
.

Oaktree Acquisition Corp. III Life Sciences' top institutional investors include AQR Arbitrage LLC (8.83%), Toronto Dominion Bank (6.41%), Toronto Dominion Bank (6.41%) and Shaolin Capital Management LLC (2.45%).

Shares of OACC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
3/31/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
Holding & other investment offices
Sub-Industry
Trading
Current Symbol
NASDAQ:OACC
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$229.63 million
Optionable
N/A
Beta
N/A
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:OACC) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners